Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | PPARG | P37231 | 1/20 | 0.59 |
| ▸ | ECE1 | P42892 | 3/20 | 0.58 |
| ▸ | HPGDS | O60760 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.54 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.54 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.54 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.54 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.54 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26428314 | 0.93 | ECE1 (0.61) | MEN1HCRTR1KMT2APPARGECE1 | |
| SCHEMBL26412803 | 0.93 | ECE1 (0.61) | MEN1HCRTR1KMT2APPARGECE1 | |
| SCHEMBL26424521 | 0.93 | MEN1 (0.64) | MEN1HCRTR1KMT2APPARGECE1 | |
| SCHEMBL31520093 | 0.91 | PPARG (0.70) | MEN1HCRTR1KMT2APPARGKDM4E | |
| SCHEMBL19051474 | 0.91 | PPARG (0.70) | MEN1HCRTR1KMT2APPARGKDM4E | |
| SCHEMBL26414216 | 0.90 | MEN1 (0.63) | MEN1HCRTR1KMT2APPARGECE1 | |
| SCHEMBL9664181 | 0.88 | MEN1 (0.64) | MEN1HCRTR1KMT2APPARGECE1 | |
| SCHEMBL16620991 | 0.87 | PPARG (0.68) | MEN1HCRTR1KMT2APPARGKDM4E | |
| SCHEMBL22851067 | 0.87 | ECE1 (0.61) | MEN1HCRTR1KMT2AECE1HPGDS | |
| SCHEMBL26424124 | 0.87 | ECE1 (0.61) | MEN1HCRTR1KMT2AECE1HPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023072971-A2 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-05-04 | — | — | WO | disclosed |
| EP-4170347-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2023-04-26 | — | — | EP | disclosed |
| US-20210355186-A1 | GLP-1 RECEPTOR ANTAGONISTS | NXERA PHARMA UK LIMITED (GB) | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355186-A1 | GLP-1 RECEPTOR ANTAGONISTS | GLP1R, GIPR, GPR119 | MEN1 1671/4885HCRTR1 69/4885KMT2A 2392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.